nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—Methyldopa—COMT—conduct disorder	0.0198	0.271	CrCbGaD
Epinephrine—Phenylephrine—MAOA—conduct disorder	0.0153	0.21	CrCbGaD
Epinephrine—Dopamine—COMT—conduct disorder	0.00965	0.132	CrCbGaD
Epinephrine—L-DOPA—DRD4—conduct disorder	0.00841	0.115	CrCbGaD
Epinephrine—Dopamine—DRD4—conduct disorder	0.00782	0.107	CrCbGaD
Epinephrine—Dopamine—MAOA—conduct disorder	0.00728	0.0998	CrCbGaD
Epinephrine—Dopamine—SLC6A4—conduct disorder	0.00469	0.0644	CrCbGaD
Epinephrine—TNF—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00217	0.00234	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—CGA—conduct disorder	0.00216	0.00233	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00216	0.00233	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—CGA—conduct disorder	0.00214	0.0023	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—CGA—conduct disorder	0.00208	0.00224	CbGpPWpGaD
Epinephrine—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00206	0.00222	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—DRD4—conduct disorder	0.00206	0.00222	CbGpPWpGaD
Epinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00206	0.00222	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—POLR3A—conduct disorder	0.00205	0.00221	CbGpPWpGaD
Epinephrine—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—conduct disorder	0.00202	0.00218	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—CGA—conduct disorder	0.00202	0.00218	CbGpPWpGaD
Epinephrine—ADRA2B—G alpha (i) signalling events—DRD4—conduct disorder	0.002	0.00216	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—CGA—conduct disorder	0.00199	0.00215	CbGpPWpGaD
Epinephrine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0019	0.00205	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—CGA—conduct disorder	0.00189	0.00204	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00187	0.00202	CbGpPWpGaD
Epinephrine—ADRA2C—G alpha (i) signalling events—DRD4—conduct disorder	0.00187	0.00202	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00186	0.002	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00183	0.00198	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—CGA—conduct disorder	0.00177	0.00191	CbGpPWpGaD
Epinephrine—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00177	0.0019	CbGpPWpGaD
Epinephrine—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00176	0.0019	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00176	0.0019	CbGpPWpGaD
Epinephrine—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00175	0.00189	CbGpPWpGaD
Epinephrine—ADRA1D—G alpha (q) signalling events—HTR2A—conduct disorder	0.00174	0.00187	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00173	0.00187	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—WASF1—conduct disorder	0.00172	0.00186	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00171	0.00184	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00164	0.00177	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—CGA—conduct disorder	0.00164	0.00177	CbGpPWpGaD
Epinephrine—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00163	0.00176	CbGpPWpGaD
Epinephrine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00162	0.00175	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00161	0.00173	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00159	0.00172	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00157	0.00169	CbGpPWpGaD
Epinephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00155	0.00168	CbGpPWpGaD
Epinephrine—ADRA2A—G alpha (i) signalling events—DRD4—conduct disorder	0.00152	0.00164	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00152	0.00164	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00151	0.00163	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00149	0.0016	CbGpPWpGaD
Epinephrine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00148	0.0016	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00146	0.00158	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—DRD4—conduct disorder	0.00145	0.00156	CbGpPWpGaD
Epinephrine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00144	0.00155	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00141	0.00152	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00141	0.00152	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CGA—conduct disorder	0.00139	0.0015	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—CGA—conduct disorder	0.00135	0.00146	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—COMT—conduct disorder	0.00135	0.00146	CbGpPWpGaD
Epinephrine—ADRB3—GPCR ligand binding—HTR2A—conduct disorder	0.00134	0.00145	CbGpPWpGaD
Epinephrine—ADRA1D—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00134	0.00145	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—DRD4—conduct disorder	0.00134	0.00145	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—MAOA—conduct disorder	0.00134	0.00145	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—DRD4—conduct disorder	0.00132	0.00142	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0013	0.0014	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00129	0.00139	CbGpPWpGaD
Epinephrine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.00128	0.00138	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—COMT—conduct disorder	0.00126	0.00136	CbGpPWpGaD
Epinephrine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00125	0.00135	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00125	0.00135	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—CGA—conduct disorder	0.00123	0.00133	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—CGA—conduct disorder	0.00123	0.00133	CbGpPWpGaD
Epinephrine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00122	0.00132	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—DRD4—conduct disorder	0.00122	0.00132	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—CGA—conduct disorder	0.00122	0.00132	CbGpPWpGaD
Epinephrine—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00121	0.00131	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—DRD4—conduct disorder	0.00121	0.00131	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00121	0.0013	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—CGA—conduct disorder	0.00121	0.0013	CbGpPWpGaD
Epinephrine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0012	0.00129	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—DRD4—conduct disorder	0.0012	0.00129	CbGpPWpGaD
Epinephrine—PAH—Metabolism—COMT—conduct disorder	0.00118	0.00127	CbGpPWpGaD
Epinephrine—PAH—Metabolism—MAOA—conduct disorder	0.00117	0.00126	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—DRD4—conduct disorder	0.00116	0.00126	CbGpPWpGaD
Epinephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00115	0.00124	CbGpPWpGaD
Epinephrine—TNF—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00115	0.00124	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00114	0.00124	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CGA—conduct disorder	0.00114	0.00123	CbGpPWpGaD
Epinephrine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00113	0.00122	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—DRD4—conduct disorder	0.00113	0.00122	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.00112	0.00121	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CGA—conduct disorder	0.00112	0.00121	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CGA—conduct disorder	0.00112	0.0012	CbGpPWpGaD
Epinephrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00111	0.0012	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.00111	0.0012	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—WASF1—conduct disorder	0.00111	0.0012	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CGA—conduct disorder	0.00111	0.0012	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CGA—conduct disorder	0.0011	0.00118	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00107	0.00115	CbGpPWpGaD
Epinephrine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00107	0.00115	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—DRD4—conduct disorder	0.00106	0.00114	CbGpPWpGaD
Epinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00105	0.00113	CbGpPWpGaD
Epinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00104	0.00112	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CGA—conduct disorder	0.00104	0.00112	CbGpPWpGaD
Epinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00102	0.00111	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.00102	0.0011	CbGpPWpGaD
Epinephrine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00101	0.00109	CbGpPWpGaD
Epinephrine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00101	0.00109	CbGpPWpGaD
Epinephrine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.001	0.00108	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000999	0.00108	CbGpPWpGaD
Epinephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00099	0.00107	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.00099	0.00107	CbGpPWpGaD
Epinephrine—TNF—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000977	0.00105	CbGpPWpGaD
Epinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00097	0.00105	CbGpPWpGaD
Epinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000954	0.00103	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—HTR2A—conduct disorder	0.000946	0.00102	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000928	0.001	CbGpPWpGaD
Epinephrine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000919	0.000992	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000919	0.000992	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000907	0.000978	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—WASF1—conduct disorder	0.000894	0.000964	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR ligand binding—HTR2A—conduct disorder	0.000876	0.000945	CbGpPWpGaD
Epinephrine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000867	0.000936	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000863	0.000931	CbGpPWpGaD
Epinephrine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000861	0.000929	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—HTR2A—conduct disorder	0.000859	0.000927	CbGpPWpGaD
Epinephrine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000855	0.000923	CbGpPWpGaD
Epinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000848	0.000915	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000843	0.000909	CbGpPWpGaD
Epinephrine—ADRB1—GPCR ligand binding—HTR2A—conduct disorder	0.000798	0.000861	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR ligand binding—HTR2A—conduct disorder	0.000791	0.000853	CbGpPWpGaD
Epinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000788	0.00085	CbGpPWpGaD
Epinephrine—ADRB2—GPCR ligand binding—HTR2A—conduct disorder	0.000781	0.000842	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—DRD4—conduct disorder	0.000778	0.000839	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—HTR2A—conduct disorder	0.00076	0.000819	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—DRD4—conduct disorder	0.000759	0.000818	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—CGA—conduct disorder	0.000753	0.000813	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—HTR2A—conduct disorder	0.000739	0.000797	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000738	0.000796	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CGA—conduct disorder	0.000733	0.00079	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000727	0.000784	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CGA—conduct disorder	0.000727	0.000784	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—EP300—conduct disorder	0.000714	0.00077	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CGA—conduct disorder	0.000702	0.000757	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—DRD4—conduct disorder	0.000691	0.000745	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—HTR2A—conduct disorder	0.00069	0.000744	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—DRD4—conduct disorder	0.000689	0.000743	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—DRD4—conduct disorder	0.000685	0.000739	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—DRD4—conduct disorder	0.000676	0.000729	CbGpPWpGaD
Epinephrine—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000669	0.000722	CbGpPWpGaD
Epinephrine—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000665	0.000717	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CGA—conduct disorder	0.000662	0.000714	CbGpPWpGaD
Epinephrine—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00066	0.000712	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CGA—conduct disorder	0.000656	0.000708	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CGA—conduct disorder	0.000648	0.000699	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	0.000646	0.000696	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—DRD4—conduct disorder	0.00064	0.00069	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	0.00063	0.000679	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—DRD4—conduct disorder	0.000628	0.000677	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—DRD4—conduct disorder	0.000625	0.000674	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—DRD4—conduct disorder	0.000622	0.000671	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—DRD4—conduct disorder	0.000614	0.000662	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CGA—conduct disorder	0.000613	0.000661	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CGA—conduct disorder	0.000603	0.00065	CbGpPWpGaD
Epinephrine—PAH—Disease—EP300—conduct disorder	0.000603	0.00065	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	0.0006	0.000647	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CGA—conduct disorder	0.000595	0.000642	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—WASF1—conduct disorder	0.000582	0.000628	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—DRD4—conduct disorder	0.000581	0.000627	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	0.000572	0.000617	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	0.000559	0.000603	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CGA—conduct disorder	0.000536	0.000578	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—WASF1—conduct disorder	0.000531	0.000572	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—WASF1—conduct disorder	0.000526	0.000567	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	0.00052	0.00056	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—WASF1—conduct disorder	0.000519	0.00056	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	0.000508	0.000548	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HTR2A—conduct disorder	0.000508	0.000548	CbGpPWpGaD
Epinephrine—PAH—Metabolism—EP300—conduct disorder	0.000505	0.000544	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CGA—conduct disorder	0.000498	0.000537	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—HTR2A—conduct disorder	0.000495	0.000534	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—WASF1—conduct disorder	0.000491	0.00053	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	0.000483	0.000521	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	0.000472	0.000509	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—EP300—conduct disorder	0.000457	0.000493	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—HTR2A—conduct disorder	0.000451	0.000486	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HTR2A—conduct disorder	0.000449	0.000485	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—HTR2A—conduct disorder	0.000447	0.000482	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—HTR2A—conduct disorder	0.000441	0.000476	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	0.000429	0.000463	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—HTR2A—conduct disorder	0.000417	0.00045	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—EP300—conduct disorder	0.000416	0.000449	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	0.000411	0.000443	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HTR2A—conduct disorder	0.000409	0.000442	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HTR2A—conduct disorder	0.000408	0.00044	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—DRD4—conduct disorder	0.000407	0.000439	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HTR2A—conduct disorder	0.000406	0.000438	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HTR2A—conduct disorder	0.000401	0.000432	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	0.000399	0.00043	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CGA—conduct disorder	0.000385	0.000415	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—EP300—conduct disorder	0.000384	0.000414	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HTR2A—conduct disorder	0.000379	0.000409	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—EP300—conduct disorder	0.000375	0.000404	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	0.000373	0.000402	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—DRD4—conduct disorder	0.000371	0.0004	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—DRD4—conduct disorder	0.000367	0.000396	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	0.000365	0.000394	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—DRD4—conduct disorder	0.000363	0.000391	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—EP300—conduct disorder	0.00035	0.000377	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—DRD4—conduct disorder	0.000343	0.00037	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—COMT—conduct disorder	0.00034	0.000367	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	0.000339	0.000366	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	0.000338	0.000364	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—MAOA—conduct disorder	0.000338	0.000364	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	0.000331	0.000357	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—COMT—conduct disorder	0.000331	0.000357	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CGA—conduct disorder	0.000329	0.000354	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—MAOA—conduct disorder	0.000328	0.000354	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—COMT—conduct disorder	0.000317	0.000342	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—MAOA—conduct disorder	0.000315	0.00034	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	0.000308	0.000332	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	0.0003	0.000324	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—EP300—conduct disorder	0.000284	0.000307	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	0.000279	0.000301	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EP300—conduct disorder	0.000269	0.00029	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—COMT—conduct disorder	0.000269	0.00029	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—MAOA—conduct disorder	0.000267	0.000288	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HTR2A—conduct disorder	0.000265	0.000286	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CGA—conduct disorder	0.000254	0.000274	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HTR2A—conduct disorder	0.000242	0.000261	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HTR2A—conduct disorder	0.00024	0.000259	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HTR2A—conduct disorder	0.000237	0.000255	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HTR2A—conduct disorder	0.000224	0.000242	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	0.00022	0.000238	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EP300—conduct disorder	0.000216	0.000233	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	0.000196	0.000211	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	0.000182	0.000196	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—COMT—conduct disorder	0.000174	0.000187	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MAOA—conduct disorder	0.000172	0.000186	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000167	0.00018	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—COMT—conduct disorder	0.000148	0.00016	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MAOA—conduct disorder	0.000147	0.000159	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—EP300—conduct disorder	0.000146	0.000157	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000143	0.000154	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—EP300—conduct disorder	0.000142	0.000153	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EP300—conduct disorder	0.000141	0.000152	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—EP300—conduct disorder	0.000136	0.000147	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EP300—conduct disorder	0.000128	0.000138	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EP300—conduct disorder	0.000127	0.000137	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EP300—conduct disorder	0.000125	0.000135	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EP300—conduct disorder	0.000119	0.000128	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EP300—conduct disorder	0.000117	0.000126	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—EP300—conduct disorder	0.000115	0.000124	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—COMT—conduct disorder	0.000114	0.000123	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MAOA—conduct disorder	0.000114	0.000123	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EP300—conduct disorder	0.000104	0.000112	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EP300—conduct disorder	9.63e-05	0.000104	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—EP300—conduct disorder	7.44e-05	8.03e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—EP300—conduct disorder	6.36e-05	6.86e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—EP300—conduct disorder	4.91e-05	5.29e-05	CbGpPWpGaD
